Return-Path: <>
Delivered-To: medisavehealth@usvip2.noc404.com
Received: from usvip2.noc404.com
by usvip2.noc404.com with LMTP
id eFZrB8UqlWnoozYAivPwkw
(envelope-from <>)
for <medisavehealth@usvip2.noc404.com>; Wed, 18 Feb 2026 02:58:13 +0000
Return-path: <>
Envelope-to: info@medisavehealthcarebd.com
Delivery-date: Wed, 18 Feb 2026 02:58:13 +0000
Received: from mail-oa1-f65.google.com ([209.85.160.65]:41543)
by usvip2.noc404.com with esmtps (TLS1.3) tls TLS_AES_128_GCM_SHA256
(Exim 4.98.1)
id 1vsXlP-0000000F4Cn-0Rel
for info@medisavehealthcarebd.com;
Wed, 18 Feb 2026 02:58:13 +0000
Received: by mail-oa1-f65.google.com with SMTP id 586e51a60fabf-40964f5bf16so214786fac.2
for <info@medisavehealthcarebd.com>; Tue, 17 Feb 2026 18:57:44 -0800 (PST)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
d=googlemail.com; s=20230601; t=1771383444; x=1771988244; darn=medisavehealthcarebd.com;
h=in-reply-to:references:subject:from:date:message-id:auto-submitted
:to:from:to:cc:subject:date:message-id:reply-to;
bh=QQffyPTg9PhncDTnt8VqjNHU8iC5Bdui6n2hyBhL7ZU=;
b=SSGZTGeQn9UVP0e6+RK5PdXXm+hDD8+qTSQaqgTmiAJJWEh8tbN/KS94/nATGxwRTN
dubHACSqoxa6pJlkixfkz/uL/xirNUMLc6NSmMS1suxsrVeXPxC5L+edXS1yyQeNAWHP
/zyKPT14xb3bkFH6zHVHBZk9QWNgvwrLdry5r8eyNdDGpb4F1nSYy2LgUPFSGbIVHQEx
u30OjS22zF23IEzOqvol9XRMmprCjmVrAIMrEjPD3/hAVOdgKfzcvWKN8HK8uRwEiREK
DQ42/WFqlw7bVG7z8DE4ZwNdKjbw+ZGxbflFHXsvzHAk1Z4kZlQtXwm3cvHfkRH36wU9
OrAQ==
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
d=1e100.net; s=20230601; t=1771383444; x=1771988244;
h=in-reply-to:references:subject:from:date:message-id:auto-submitted
:to:x-gm-message-state:from:to:cc:subject:date:message-id:reply-to;
bh=QQffyPTg9PhncDTnt8VqjNHU8iC5Bdui6n2hyBhL7ZU=;
b=X/ToFRIDFJpyvlftRxvQRxLsXWQQAXu1rijyIdOT2H9JgnhRuflBLrmB9h9BQXr+pk
yAy8uIOkz2eIzvI0wbtOb5ajVw2kYdjd1xJc10kPtQrFHtGD2N0U67O8VhN40qfJVE1N
YFl53gNYijvZVweNnLJSQisNIByU9aG+kA0x9epchhEydV0NSRKjsPDszdp9zQ/t9sce
bVvyUgpL7kPN/BZs7QxZNrpV056zP5XzuI9i3DDH6dAxIudRLIKnGodAxPIKstmIyJsU
Yz1VYidly+Pdr2v69mSPZF6X8db2X9gadUCc3nHmH877hyZLBEa11SRVZ0Zw3gvQiYsg
uOMA==
X-Gm-Message-State: AOJu0YxfzvHnoVW9oazTsifZWw2ffw6LRV2ZwNMSIxzqE67yFht4gjbQ
eHV5oDW7sjtIsT5uKvjlPYsSLzWL0SuXKqtP3P48c6qK1RG6H0GFVO1FUxKRgAH/0Ckaioazlfr
+YsAfxF8QAM2uwWOOUNGKNzNG21QCsxN08YWPbf7IEJm2N30AYBTHcWNtDg==
X-Received: by 2002:a05:6830:348d:b0:7d1:474a:191f with SMTP id 46e09a7af769-7d4c2c2c106mr7893676a34.0.1771383444224;
Tue, 17 Feb 2026 18:57:24 -0800 (PST)
Content-Type: multipart/report; boundary="000000000000f435e2064b105812"; report-type=delivery-status
To: info@medisavehealthcarebd.com
Received: by 2002:a05:6830:348d:b0:7d1:474a:191f with SMTP id
46e09a7af769-7d4c2c2c106mr11046917a34.0; Tue, 17 Feb 2026 18:57:24 -0800 (PST)
Auto-Submitted: auto-replied
Message-ID: <69952a94.050a0220.38ab25.edca.GMR@mx.google.com>
Date: Tue, 17 Feb 2026 18:57:24 -0800 (PST)
From: Mail Delivery Subsystem <mailer-daemon@googlemail.com>
Subject: Delivery Status Notification (Failure)
References: <177138343700.270981.10840357104779405808@medisavehealthcarebd.com>
In-Reply-To: <177138343700.270981.10840357104779405808@medisavehealthcarebd.com>
X-Failed-Recipients: events@benzinga.com
X-Spam-Status: No, score=2.2
X-Spam-Score: 22
X-Spam-Bar: ++
X-Ham-Report: Spam detection software, running on the system "usvip2.noc404.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: ** Message blocked ** Your message to events@benzinga.com
has been blocked. See technical details below for more information. Learn
more here: https://support.google.com/a/answer/168383
Content analysis details: (2.2 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked.
See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URI: noc404.com]
[URI: medisavehealthcarebd.com]
[URI: googlemail.com]
[URI: benzinga.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[209.85.160.65 listed in sa-trusted.bondedsender.org]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[209.85.160.65 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[209.85.160.65 listed in sa-accredit.habeas.com]
0.0 T_SPF_HELO_TEMPERROR SPF: test of HELO record failed (temperror)
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's
domain
0.0 FREEMAIL_FROM Sender email is commonly abused enduser mail provider
[mailer-daemon(at)googlemail.com]
1.5 KAM_MXURI URI: URI begins with a mail exchange prefix, i.e. mx.[...]
0.7 HTML_IMAGE_ONLY_20 BODY: HTML: images with 1600-2000 bytes of words
0.0 HTML_MESSAGE BODY: HTML included in message
0.1 MIME_HEADER_CTYPE_ONLY 'Content-Type' found without required MIME
headers
X-Spam-Flag: NO
--000000000000f435e2064b105812
Content-Type: multipart/related; boundary="000000000000f43629064b105813"
--000000000000f43629064b105813
Content-Type: multipart/alternative; boundary="000000000000f4362c064b105814"
--000000000000f4362c064b105814
Content-Type: text/plain; charset="UTF-8"
** Message blocked **
Your message to events@benzinga.com has been blocked. See technical details below for more information.
Learn more here: https://support.google.com/a/answer/168383
The response was:
Your email to group events@benzinga.com was rejected due to spam classification.
The owner of the group can choose to enable message moderation instead of bouncing these emails.
More information can be found here: https://support.google.com/a/answer/168383.
--000000000000f4362c064b105814
Content-Type: text/html; charset="UTF-8"
<html>
<head>
<style>
* {
font-family:Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif;
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" class="email-wrapper" style="padding-top:32px;background-color:#ffffff;"><tbody>
<tr><td>
<table cellpadding=0 cellspacing=0><tbody>
<tr><td style="max-width:560px;padding:24px 24px 32px;background-color:#fafafa;border:1px solid #e0e0e0;border-radius:2px">
<img style="padding:0 24px 16px 0;float:left" width=72 height=72 alt="Error Icon" src="cid:icon.png">
<table style="min-width:272px;padding-top:8px"><tbody>
<tr><td><h2 style="font-size:20px;color:#212121;font-weight:bold;margin:0">
Message blocked
</h2></td></tr>
<tr><td style="padding-top:20px;color:#757575;font-size:16px;font-weight:normal;text-align:left">
Your message to <a style='color:#212121;text-decoration:none'><b>events@benzinga.com</b></a> has been blocked. See technical details below for more information.
</td></tr>
<tr><td style="padding-top:24px;color:#4285F4;font-size:14px;font-weight:bold;text-align:left">
<a style="text-decoration:none" href="https://support.google.com/a/answer/168383">LEARN MORE</a>
</td></tr>
</tbody></table>
</td></tr>
</tbody></table>
</td></tr>
<tr style="border:none;background-color:#fff;font-size:12.8px;width:90%">
<td align="left" style="padding:48px 10px">
The response was:<br/>
<p style="font-family:monospace">
Your email to group events@benzinga.com was rejected due to spam classification.
The owner of the group can choose to enable message moderation instead of bouncing these emails.
More information can be found here: https://support.google.com/a/answer/168383.
</p>
</td>
</tr>
</tbody></table>
</body>
</html>
--000000000000f4362c064b105814--
--000000000000f43629064b105813
Content-Type: image/png; name="icon.png"
Content-Disposition: attachment; filename="icon.png"
Content-Transfer-Encoding: base64
Content-ID: <icon.png>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==
--000000000000f43629064b105813--
--000000000000f435e2064b105812
Content-Type: message/delivery-status
Reporting-MTA: dns; googlemail.com
Received-From-MTA: dns; info@medisavehealthcarebd.com
Arrival-Date: Tue, 17 Feb 2026 18:57:23 -0800 (PST)
X-Original-Message-ID: <177138343700.270981.10840357104779405808@medisavehealthcarebd.com>
Final-Recipient: rfc822; events@benzinga.com
Action: failed
Status: 5.7.1
Diagnostic-Code: smtp; Your email to group events@benzinga.com was rejected due to spam classification.
The owner of the group can choose to enable message moderation instead of bouncing these emails.
More information can be found here: https://support.google.com/a/answer/168383.
Last-Attempt-Date: Tue, 17 Feb 2026 18:57:24 -0800 (PST)
--000000000000f435e2064b105812
Content-Type: text/rfc822-headers
X-Received: by 2002:a05:6830:348d:b0:7d1:474a:191f with SMTP id 46e09a7af769-7d4c2c2c106mr7893671a34.0.1771383443759;
Tue, 17 Feb 2026 18:57:23 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1771383443; cv=none;
d=google.com; s=arc-20240605;
b=Bn7kJBjAb0iKusVyInlZw/dW0wTuPhXBh/wuxaTYLNZ0YQeOdEutTGz2gBfu6EU6gX
Il9vdlkmBPVQn1lJiRkMTW6Q1JVeoDns0Op9LOSHM+Ggaf/xZN4oFB5hOrNtRGd0AqO7
Af1/moYERR4f324q0SMAWQ/8V3LCc4U9A1fXVph/qJbfodDVogT4BNBA4uTdT3M0e0CZ
F0gAqty5JfFqLeMAcfJDtPZ7kAkHATFz5a1UyQ60HCX5Oe+7QztcgshyV2AHmoX2Kxjq
l5gol10yeM0W0PuXTH0CCArxl479RH04wV6Jc8SBc8nadxZGAqAvGnWXa5UujLEsxKkk
gLXw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605;
h=priority:importance:list-unsubscribe-post:list-unsubscribe
:feedback-id:content-transfer-encoding:message-id:subject:to:from
:date:mime-version;
bh=ycJoruD4nUR3xTWAZGNyoKoltmmC/3EqrfxvmkMcwcY=;
fh=94BZ8i8YxMZOQdbAwUS3UW9LJ/+BPFm0uCs7tgcQh74=;
b=O5BL6gqrRGsvl+Kx49+BiBU+4I6coPKQdB3OGy2GrMMH/W1bTyBAYxSXfqdPzuPx6N
RtlhFnzcuWrnO582Oyr7Hy1h6Di+D54RRj1+mbs1w+rkuxMFN9UbE4/trhT7uQ44rYSA
gsdfcW/VuzxJdLgI2ei+/nXDGAltlh+riThU2hYtK8hR4RRmOzvpA7UDHI305WYKz7pX
zQvxFuT97Q0ofM613RQipzrfatlEitT8SLKWbFuZFDgFZQjHQiDLRBc2KYHVrEzt3IOP
dd7aIkUnEj967JESJAJX51eckQY1LMCKm+Bzm7DDREzLy1yyy1nXgGw6b4P0f9tRM66t
tmGw==;
dara=google.com
ARC-Authentication-Results: i=1; mx.google.com;
spf=pass (google.com: domain of info@medisavehealthcarebd.com designates 192.200.120.82 as permitted sender) smtp.mailfrom=info@medisavehealthcarebd.com
Return-Path: <info@medisavehealthcarebd.com>
Received: from usvip2.noc404.com (usvip2.noc404.com. [192.200.120.82])
by mx.google.com with ESMTPS id 46e09a7af769-7d4bc32deb7si9795636a34.152.2026.02.17.18.57.23
for <events@benzinga.com>
(version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256);
Tue, 17 Feb 2026 18:57:23 -0800 (PST)
Received-SPF: pass (google.com: domain of info@medisavehealthcarebd.com designates 192.200.120.82 as permitted sender) client-ip=192.200.120.82;
Authentication-Results: mx.google.com;
spf=pass (google.com: domain of info@medisavehealthcarebd.com designates 192.200.120.82 as permitted sender) smtp.mailfrom=info@medisavehealthcarebd.com
Received: from [169.155.255.16] (port=60160 helo=[172.67.194.152])
by usvip2.noc404.com with esmtpsa (TLS1.3) tls TLS_AES_256_GCM_SHA384
(Exim 4.98.1)
(envelope-from <info@medisavehealthcarebd.com>)
id 1vsXki-0000000F40C-3NNf
for events@benzinga.com;
Wed, 18 Feb 2026 02:57:23 +0000
Content-Type: multipart/related; boundary="----=_Part_ccc35465ff2561.1e8ee27cf5154bba"
MIME-Version: 1.0
Date: Wed, 18 Feb 2026 04:57:17 +0200
From: AvniSupport <info@medisavehealthcarebd.com>
To: events@benzinga.com
Subject: Current Invoice Notification_#89cc86ee-5648-a110-22f0-e63d4693390e
Message-ID: <177138343700.270981.10840357104779405808@medisavehealthcarebd.com>
Content-Transfer-Encoding: quoted-printable
Feedback-ID: campaign-1c013983@medisavehealthcarebd.com
X-MSMail-Header: Medisavehealthcarebd
List-Unsubscribe: <mailto:unsubscribe@medisavehealthcarebd.com>, <https://medisavehealthcarebd.com/unsubscribe?email=events%40benzinga.com&t=1381dc03>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Priority: 1
Importance: High
Priority: urgent
X-AntiAbuse: This header was added to track abuse, please include it with any abuse report
X-AntiAbuse: Primary Hostname - usvip2.noc404.com
X-AntiAbuse: Original Domain - benzinga.com
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - medisavehealthcarebd.com
X-Get-Message-Sender-Via: usvip2.noc404.com: authenticated_id: 3@nova-lamb-187.medisavehealthcarebd.com
X-Authenticated-Sender: usvip2.noc404.com: 3@nova-lamb-187.medisavehealthcarebd.com
X-Source:
X-Source-Args:
X-Source-Dir:
--000000000000f435e2064b105812--
|